newsfilter
← Latest News
GlobeNewswire·

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) ("Indaptus" or the "Company"), a biotechnology company dedicated to immunotherapy research, today announced